revolade 25mg film tableta
"novartis pharma services ag" dio stranog druŠtva podgorica - eltrombopag - film tableta - 25mg
revolade 50mg film tableta
"novartis pharma services ag" dio stranog druŠtva podgorica - eltrombopag - film tableta - 50mg
elmopag 50mg film tableta
"glk pharma" druŠtvo sa ograniČenom odgovornoŠĆu, podgorica - eltrombopag - film tableta - 50mg
elmopag 25mg film tableta
"glk pharma" druŠtvo sa ograniČenom odgovornoŠĆu, podgorica - eltrombopag - film tableta - 25mg
revolade 25 mg/1 tableta filmom obložena tableta
novartis ba d.o.o. - eltrombopag - filmom obložena tableta - 25 mg/1 tableta - 1 filmom obložena tableta sadrži: 25 mg eltrombopag (u obliku eltrombopag olamina)
revolade 50 mg/1 tableta filmom obložena tableta
novartis ba d.o.o. - eltrombopag - filmom obložena tableta - 50 mg/1 tableta - 1 filmom obložena tableta sadrži: 50 mg eltrombopag (u obliku eltrombopag olamina)
revolade
novartis europharm limited - eltrombopag - purpura, trombocitopenična, idiopatska - other systemic hemostatics, antihemorrhagics - revolade is indicated for the treatment of adult patients with primary immune thrombocytopenia (itp) who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 i 5. revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia (itp) lasting 6 months or longer from diagnosis and who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 i 5. revolade is indicated in adult patients with chronic hepatitis c virus (hcv) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy (see sections 4. 4 and 5. revolade is indicated in adult patients with acquired severe aplastic anaemia (saa) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable for haematopoietic stem cell transplantation (see section 5.
hepcludex
gilead sciences ireland uc - bulevirtide acetate - hepatitis d, chronic - antivirusni lijekovi za sustavnu uporabu - hepcludex is indicated for the treatment of chronic hepatitis delta virus (hdv) infection in plasma (or serum) hdv-rna positive adult patients with compensated liver disease.
teokap sr 300 mg/1 kapsula kapsula sa produženim oslobađanjem, tvrda
nobel lijek d.o.o. sarajevo - teofilin - kapsula sa produženim oslobađanjem, tvrda - 300 mg/1 kapsula - 1 kapsula sa produženim oslobađanjem, tvrda sadrži: 300 mg teofilina
teokap sr 200 mg/1 kapsula kapsula sa produženim oslobađanjem, tvrda
nobel lijek d.o.o. sarajevo - teofilin - kapsula sa produženim oslobađanjem, tvrda - 200 mg/1 kapsula - 1 kapsula sa produženim oslobađanjem, tvrda sadrži: 200 mg teofilina